Neogen Chemicals Ltd. Share Price

Neogen Chemicals manufactures specialty organic

Strengths - Specialty chemical expertise: Experience in complex chemistry and organolithium products creates technical barriers to entry. - Strong Q1 earnings growth: EBITDA grew faster than revenue, indicating improved operating leverage and product mix. - Battery-materials opportunity: Neogen Ionics provides exposure to the developing lithium-ion battery ecosystem. Its Q1 FY27 revenue reportedly tripled year-on-year. Weaknesses - High finance costs: Expansion-related borrowing can absorb a significant portion of operating profits. - Profitability still developing: Q1 FY27 PAT was ₹17.11 crore against revenue of ₹250.29 crore, equivalent to a net margin of approximately 6.8%. Opportunities - Electric vehicles: Growth in electric vehicles can increase demand for lithium-ion battery materials. - Energy storage: Stationary battery storage and renewable-energy integration may create additional demand over time. - Import substitution: Domestic production of specialised chemicals and battery materials could benefit from customers seeking local supply chains. Threats - Battery-sector competition: Established international suppliers and new domestic entrants may put pressure on prices and returns. - Raw-material volatility: Lithium-related inputs, solvents, energy and other chemical feedstocks can affect profitability. - Execution and commissioning risks: Delays, quality issues or slower customer approvals could postpone expected battery-business revenue. - Leverage and dilution risk: Additional capital expenditure may require more borrowing or equity fundraising. The company has considered fundraising of up to ₹600 crore.

See More

Neogen Chemicals hits record high after breakout

Neogen Chemicals Limited shares hit a fresh all-time high of Rs 2,785 after an ascending triangle breakout. Rs 2,500 is now support. Neogen Chemicals Limited [

] shares extended their gains for the third straight session and hit a fresh all-time high of Rs 2,785 in morning trade. The move came after a breakout from an ascending triangle on the daily chart. An ascending triangle forms when price makes higher lows against a flat resistance level. A breakout above that level is often read as a continuation of the uptrend, though a breakout can also fail if the price falls back inside the pattern. The Rs 2,500 zone, which was resistance earlier, has now turned into support. With the stock at an all-time high, there is no earlier resistance on the chart, so the higher levels are untouched territory. In my view, the trend is strongly bullish. The stock has moved out of its consolidation with three straight gains and a record high. A hold above Rs 2,500 would keep the breakout intact. A fall back below it would put the pattern at risk and bring lower levels into view. After a sharp run, the stock can pause or retest the breakout zone. Bullish view while price holds above Rs 2,500. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.

See More

NSE: CYIENTDLM | Swing trading watchlist ₹1,047.50

NSE: CYIENTDLM | Swing trading watchlist ₹1,047.50 +3.58% 14 October 2026, 10:53 AM snapshot Cyient DLM is showing encouraging technical strength, with its share price moving above the previous 52-week high of ₹1,020. The stock has gained approximately 15.82% over one month and 99.28% over three months, indicating strong medium-term momentum. Dhan Technical trading setup: - Breakout reference: ₹1,020 - Bullish confirmation: Sustained trading above ₹1,050 with strong volume - Immediate support to monitor: ₹1,020 - Risk: A sustained move below ₹1,020 could signal a failed breakout - Time horizon: 5–15 trading sessions The stock is trading above its 50-day and 200-day moving averages, while RSI near 65 indicates positive momentum without being at an extreme overbought reading. However, the strong recent rally increases the risk of profit booking. Second stock: Neogen Chemicals Neogen Chemicals traded around ₹2,768, up 7.72% in the morning snapshot, crossing its previous 52-week high of ₹2,615. Its RSI was approximately 64.6, and the stock was trading above both major moving averages. Dhan A sustained breakout above ₹2,615 is constructive, but traders should avoid chasing a sharp rally without a pullback or consolidation. My preferred stock to monitor for a fresh swing entry: Cyient DLM, subject to volume confirmation and price holding above the breakout zone. These are technical watchlists, not confirmed entry signals.

See More

⚗️ NEOGEN CHEMICALS — THE BATTERY CHEMISTRY OPPORTUNITY! 🔋

The EV revolution needs more than batteries. It needs the chemistry that makes those batteries work. Neogen Chemicals operates in specialised chemical manufacturing, with exposure to organolithium compounds, inorganic chemicals and battery materials. Its long-term story lies in moving beyond its established specialty-chemicals business and scaling its battery-chemistry ambitions. 📊 Q1 FY27: GROWTH IS ACCELERATING 💰 Revenue: ₹250.3 crore, up 34% YoY. 🚀 EBITDA: ₹48.2 crore, up 53%. 📈 Net profit: ₹17.1 crore, up around 67%. 🔥 Consolidated EBITDA margin improved to 19.3%, versus 16.9% a year earlier. Neogen Ionics, its battery-chemicals subsidiary, generated ₹19 crore in revenue compared with ₹5 crore in the year-ago quarter. 🚀 WHAT COULD DRIVE THE NEXT LEG? ✅ Battery materials: Growing battery manufacturing capacity could create demand for electrolyte chemicals and related materials. ✅ Specialty chemicals: Organolithium and inorganic chemicals provide an established business alongside the newer battery opportunity. ✅ Capacity expansion: The Dahej plant reconstruction and battery-chemicals investments could support future growth as projects ramp up. ✅ Operating leverage: If volumes rise and new facilities utilise capacity efficiently, profitability could improve further. ⚠️ THE RISKS YOU CANNOT IGNORE Finance costs rose approximately 64% YoY to ₹20.8 crore in Q1 FY27, reflecting higher debt and working-capital requirements. The Dahej reconstruction, capital expenditure, commissioning timelines and slower-than-expected battery-cell expansion could all affect returns. 🎯 THE BOTTOM LINE Neogen combines a growing specialty-chemicals business with a potentially significant battery-materials opportunity. But the real test is whether expansion translates into sustainable cash flow, manageable debt and consistent earnings. The battery opportunity is exciting. Execution will decide the chemistry of returns.

See More

Neogen Chemicals Forms Symmetrical Triangle Near Highs

Neogen Chemicals shares ended 0.06% lower at Rs 2,378.20 on 9 October 2026. A symmetrical triangle signals consolidation, with support at Rs 2,300. Neogen Chemicals Limited [

] shares ended 0.06% lower at Rs 2,378.20 on 9 October 2026, the last trading session of the week. The stock continues to trade near its December 2024 high zone. The stock hit a recent high of Rs 2,499.70 on 21 September. Since then, it has formed lower highs and higher lows, creating a symmetrical triangle on the daily chart. The narrowing price range indicates consolidation following the previous rally. A symmetrical triangle reflects a period of balance between buyers and sellers. Although the pattern can signal trend continuation, a breakout in either direction remains possible. Relatively low volume during consolidation suggests limited selling pressure. The Relative Strength Index (RSI) stands at 53.22, below its average of 57.04, indicating cooling momentum without a clear bearish signal. The broader technical structure remains bullish as the stock continues to hold near its highs. A decisive breakout above Rs 2,500 could open the door to fresh highs. Conversely, a breakdown below Rs 2,300 may weaken the bullish structure and expose the stock to further downside. Key Levels: Resistance at Rs 2,500 | Support at Rs 2,300. My View: At this juncture the bullish bias expected to remains intact while the stock holds above Rs 2,300, with a breakout above Rs 2,500 needed to signal renewed upward momentum. Disclosure & Disclaimer: I and my family members do not hold any position in the stock discussed. This content is provided solely for informational and educational purposes and should not be construed as investment advice or a recommendation to buy or sell any security. Investments in the securities market are subject to market risks. Please read all related documents carefully before investing.

See More

NEOGEN CHEMICALS RAISES ₹600 CRORE VIA QIP

N Chemicals Limited has completed its first-ever Qualified Institutional Placement, raising nearly ₹600 crore. The QIP was oversubscribed by more than 6.5 times, indicating strong institutional demand for the issue. The company allotted around 26.6 lakh equity shares at ₹2,255 per share. Interestingly, the issue price was above the QIP floor price of ₹2,189.73. The fundraise saw participation from domestic and global institutional investors, including mutual funds, insurance companies and foreign portfolio investors. Why does this matter? Neogen plans to use the proceeds partly for repayment or prepayment of borrowings and long-term working capital requirements. Reducing debt could lower finance costs and improve the company’s debt-to-equity position, while additional working capital provides room to support future expansion. My view: The 6.5x subscription is an important signal of institutional interest, but the bigger fundamental trigger will be how efficiently the fresh capital translates into balance-sheet improvement and earnings growth. The stock has already seen a strong run in 2026, so valuation and execution become increasingly important from here. What I am watching next: Track debt reduction over the coming quarters, working-capital trends and management commentary on deployment of the QIP proceeds. For the stock, the recent 52-week high near ₹2,498 becomes an important reference zone. Sustained strength above this area could indicate continuation of momentum, while failure to hold recent gains may lead to consolidation. View: Positive development fundamentally, but fresh entries should consider valuation and price confirmation. Disclosure: I have no holding or financial interest in Neogen Chemicals Limited.

See More